Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists
Laure Gossec(Inserm), Maxime Dougados(Délégation Paris 5), Tore K Kvien(Diakonhjemmet Hospital), Helena Canhão(University of Lisbon), César Ramos-Remus(Universidad Enrique Díaz de León), Ivânio Alves Pereira, Jane Zochling(Royal North Shore Hospital), Vedat Hamuryudan(Istanbul University), J. W. J. Bijlsma(University Medical Center Utrecht), Claire Bombardier(Toronto General Hospital), Mikkel Østergaard(University of Copenhagen), Burkhard F. Leeb, Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), J Devlin(University Hospital Waterford), Herman Mielants(Ghent University), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), E. Martín‐Mola(Hospital Universitario La Paz)
Cited by 6
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
|New England Journal of Medicine|2000|4k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k